Cafepharma Today

May 31 2023 - Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff
Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff
Merck study: mRNA technology a ‘game changer’ for Asia-Pacific vaccine manufacturers
Sanofi sees midphase success in multiple sclerosis decades after safety concerns scuttled peers
Key FDA decisions on the horizon
*please scroll down for all the latest news*

Current News

submit a press release

Click here to stay updated on CP happenings
Pharma world braces for major changes in new era of AI
Clinical Trials Arena
Wednesday, May 24, 2023 - 6:43pm
tags:
pharma industry, artificial intelligence
PTC Cuts Early-Stage Pipeline but Pushes Forward on FA Drug After Phase III Flop
BioSpace
Wednesday, May 24, 2023 - 6:42pm
tags:
PTC Therapeutics, Friedreich's Ataxia, clinical trials, vatiquinone
FDA clears Braeburn's long-acting Brixadi to treat opioid use disorder
Fierce Pharma
Wednesday, May 24, 2023 - 6:38pm
tags:
Braeburn Pharmaceuticals, FDA, Brixadi, opioids, opioid use disorder
FTC probes Abbott for allegedly colluding on bids for state contracts
Medical Marketing and Media
Wednesday, May 24, 2023 - 11:27am
tags:
Abbott Labs, Nestle, Reckitt Benckiser, collusion, FTC, state contracts
Innoviva subsidiary Entasis scores FDA nod for bacterial pneumonia combo drug Xacduro
Fierce Pharma
Wednesday, May 24, 2023 - 11:25am
tags:
Innoviva, FDA, Entasis Therapeutics, Xacduro, ventilator-associated bacterial pneumonia, hospital-acquired bacterial pneumonia
FDA delays decision on Duchenne gene therapy and considers narrower approval
BioPharma Dive
Wednesday, May 24, 2023 - 11:21am
tags:
Sarepta Therapeutics, FDA, DMD, Duchenne Muscular Dystrophy, gene therapy
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Motley Fool
Wednesday, May 24, 2023 - 11:18am
tags:
FTC, M&A, Amgen, Horizon Therapeutics, Pfizer, Seagen
How Vivek Ramaswamy helped make Martin Shkreli the ‘pharma bro’
Politico
Wednesday, May 24, 2023 - 10:26am
tags:
Vivek Ramaswamy, Martin Shkreli
ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth
BioSpace
Wednesday, May 24, 2023 - 10:24am
tags:
ElevateBio, funding, cell therapy, gene therapy
Bayer's acting BD chief lobbies for the job the only way he knows how: by making deals
Fierce Biotech
Wednesday, May 24, 2023 - 10:23am
tags:
Bayer, business development
Why Is CVS Health Clinical Trial Services Closing?
Xtalks
Wednesday, May 24, 2023 - 10:21am
tags:
CVS Health, clinical trials
Novo makes a gene editing move
EP Vantage
Wednesday, May 24, 2023 - 10:20am
tags:
Novo Nordisk, gene editing, Life Edit Therapeutics
How tranScrip CEO Marcin Mankowski is ‘driving forward’ drug innovation and development
Biopharma Reporter
Wednesday, May 24, 2023 - 10:16am
tags:
drug development, tranScrip, innovation
Merck’s Gardasil Under Legal Scrutiny Despite Lack of Evidence to Support Suits
BioSpace
Wednesday, May 24, 2023 - 10:15am
tags:
Merck, vaccines, Gardasil, legal, HPV, side effects
Rain Oncology Plummets after Lead Candidate Disappoints in Phase 3
Tip Ranks
Wednesday, May 24, 2023 - 10:14am
tags:
Rain Oncology, liposarcoma, clinical trials, milademetan
Bayer, Amgen looked at Iveric before agreeing to Astellas sale
Seeking Alpha
Tuesday, May 23, 2023 - 6:20pm
tags:
Astellas, Iveric Bio, Bayer, Amgen, M&A
Orthopedic markets to return to normal this year as post-pandemic boost fades: analysts
Medtech Dive
Tuesday, May 23, 2023 - 6:17pm
tags:
Medtech, Orthopedics, pandemic, COVID-19
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
Yahoo/Reuters
Tuesday, May 23, 2023 - 6:14pm
tags:
JNJ, Amgen, patents, Stelara, biosimilars, legal
Bristol Myers Squibb eyes phase 3 after pulmonary fibrosis drug reduces lung function decline
Fierce Biotech
Tuesday, May 23, 2023 - 6:12pm
tags:
Bristol Myers Squibb, clinical trials, BMS-986278, idiopathic pulmonary fibrosis
Top three unmet needs to target in Parkinson’s disease
Clinical Trials Arena
Tuesday, May 23, 2023 - 6:08pm
tags:
Parkinson's Disease, drug devlopment

Pages

Latest CP Wire Articles

Eastman introduces new excipient to formulate poorly soluble API
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award
PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
Klick Health launches new healthcare venture studio
Medtech earnings reports: insights from major players' Q4 results
Key compliance issues for medtech firms transitioning to data-enabled solutions
Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine

Latest Pharmagather Articles

Timeless
In the Pipeline
Drug Channels News Roundup, May 2023: 340B Shame, OptumRx vs. Humira Biosimilars, ICER on White Bagging, Hospitals vs. Taxes, and Dr. G
Drug Channels
AI and the Hard Stuff
In the Pipeline
Break Out the Purple Carrots
In the Pipeline
Five (or Maybe Six?) Reasons that the Largest PBMs Operate Group Purchasing Organizations
Drug Channels
Give Me Those Hard, Hard Numbers
In the Pipeline
The Top Pharmacy Benefit Managers of 2022: Market Share and Trends for the Biggest Companies
Drug Channels
What Exactly Does Ketamine Do For Depression?
In the Pipeline
PBMs and the Battle Over Patient Support Funds:Accumulators, Maximizers, and Alternative Funding (NEW Live Video Webinar)
Drug Channels

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information